Masataka Adachi

1.7k total citations
51 papers, 1.3k citations indexed

About

Masataka Adachi is a scholar working on Molecular Biology, Nephrology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Masataka Adachi has authored 51 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 17 papers in Nephrology and 14 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Masataka Adachi's work include Ion Transport and Channel Regulation (18 papers), Hormonal Regulation and Hypertension (12 papers) and Electrolyte and hormonal disorders (8 papers). Masataka Adachi is often cited by papers focused on Ion Transport and Channel Regulation (18 papers), Hormonal Regulation and Hypertension (12 papers) and Electrolyte and hormonal disorders (8 papers). Masataka Adachi collaborates with scholars based in Japan, United States and Spain. Masataka Adachi's co-authors include Kenichiro Kitamura, Kimio Tomita, Taku Miyoshi, Naoki Shiraishi, Hiroshi Nonoguchi, Takefumi Narikiyo, Kozo Iwashita, Yutaka Kakizoe, Naoki Wakida and Larry Schneck and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Masataka Adachi

43 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masataka Adachi Japan 20 694 327 316 227 204 51 1.3k
Takayasu Mori Japan 21 1.1k 1.7× 260 0.8× 321 1.0× 271 1.2× 187 0.9× 115 1.6k
Eliezer J. Holtzman Israel 25 1.2k 1.7× 437 1.3× 395 1.3× 278 1.2× 305 1.5× 69 2.1k
Tetsuro Kusaba Japan 18 624 0.9× 536 1.6× 200 0.6× 90 0.4× 224 1.1× 66 1.4k
Taku Miyoshi Japan 17 587 0.8× 261 0.8× 265 0.8× 207 0.9× 78 0.4× 26 949
Andrea Pasini Italy 23 378 0.5× 414 1.3× 186 0.6× 168 0.7× 169 0.8× 67 1.6k
Matthias T. F. Wolf United States 24 1.3k 1.9× 522 1.6× 511 1.6× 139 0.6× 132 0.6× 58 2.3k
Daryl M. Okamura United States 19 521 0.8× 464 1.4× 207 0.7× 75 0.3× 192 0.9× 34 1.4k
Liang Fang United States 12 804 1.2× 196 0.6× 159 0.5× 98 0.4× 93 0.5× 26 1.4k
Kohei Uchimura Japan 13 1.1k 1.6× 543 1.7× 382 1.2× 127 0.6× 249 1.2× 24 1.8k
Weier Qi Australia 23 637 0.9× 306 0.9× 117 0.4× 178 0.8× 164 0.8× 28 1.3k

Countries citing papers authored by Masataka Adachi

Since Specialization
Citations

This map shows the geographic impact of Masataka Adachi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masataka Adachi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masataka Adachi more than expected).

Fields of papers citing papers by Masataka Adachi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masataka Adachi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masataka Adachi. The network helps show where Masataka Adachi may publish in the future.

Co-authorship network of co-authors of Masataka Adachi

This figure shows the co-authorship network connecting the top 25 collaborators of Masataka Adachi. A scholar is included among the top collaborators of Masataka Adachi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masataka Adachi. Masataka Adachi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kuwabara, Takashige, Teruhiko Mizumoto, Yutaka Kakizoe, et al.. (2025). WCN25-275 A CASE OF THROMBOTIC MICROANGIOPATHY IN LUPUS NEPHRITIS FOLLOWING TREATMENT WITH MOGAMULIZUMAB, ANTI-CCR4 ANTIBODY, FOR ADULT T CELL LEUKEMIA. Kidney International Reports. 10(2). S86–S86.
2.
Fujimoto, Daisuke, Teruhiko Mizumoto, Jingxuan Zhang, et al.. (2025). Alvespimycin is identified as a novel therapeutic agent for diabetic kidney disease by chemical screening targeting extracellular vesicles. Scientific Reports. 15(1). 14436–14436.
3.
Kakizoe, Yutaka, Miyuki Nakagawa, Yuki Narita, et al.. (2023). A Serine Protease Inhibitor, Camostat Mesilate, Suppresses Urinary Plasmin Activity and Alleviates Hypertension and Podocyte Injury in Dahl Salt-Sensitive Rats. International Journal of Molecular Sciences. 24(21). 15743–15743. 1 indexed citations
4.
Morinaga, Jun, Yushi Nakayama, Masataka Adachi, et al.. (2023). Association between prognostic nutritional index and peritoneal dialysis discontinuation: a retrospective cohort study. Renal Replacement Therapy. 9(1).
5.
Kakizoe, Yutaka, Masataka Adachi, Yuki Narita, et al.. (2022). The serine protease plasmin plays detrimental roles in epithelial sodium channel activation and podocyte injury in Dahl salt-sensitive rats. Hypertension Research. 46(1). 50–62. 8 indexed citations
6.
Yoshizawa, Tatsuya, Yoshifumi Sato, Yuko Miyasato, et al.. (2018). Sirtuin 7 Deficiency Ameliorates Cisplatin-induced Acute Kidney Injury Through Regulation of the Inflammatory Response. Scientific Reports. 8(1). 5927–5927. 55 indexed citations
7.
Narita, Yuki, Miki Ueda, Kohei Uchimura, et al.. (2016). Combination therapy with renin-angiotensin-aldosterone system inhibitor telmisartan and serine protease inhibitor camostat mesilate provides further renoprotection in a rat chronic kidney disease model. Journal of Pharmacological Sciences. 130(2). 110–116. 12 indexed citations
8.
Ueda, Miki, Kohei Uchimura, Yuki Narita, et al.. (2015). The Serine Protease Inhibitor Camostat Mesilate Attenuates the Progression of Chronic Kidney Disease through its Antioxidant Effects. ˜The œNephron journals/Nephron journals. 129(3). 223–232. 13 indexed citations
9.
Uchimura, Kohei, Teruhiko Mizumoto, Yutaka Kakizoe, et al.. (2014). The serine protease prostasin regulates hepatic insulin sensitivity by modulating TLR4 signalling. Nature Communications. 5(1). 3428–3428. 46 indexed citations
10.
Odagiri, Kazumasa, Motoko Omura, Masaharu Hata, et al.. (2012). Treatment Outcomes, Growth Height, and Neuroendocrine Functions in Patients With Intracranial Germ Cell Tumors Treated With Chemoradiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 84(3). 632–638. 33 indexed citations
11.
Yamashita, Akiko, Masataka Adachi, Haruhiko Noda, et al.. (2010). Periodontal disease and hypertriglyceridemia in Japanese subjects: potential association with enhanced lipolysis. Metabolism. 60(6). 823–829. 31 indexed citations
12.
Kakizoe, Yutaka, Kenichiro Kitamura, Naoki Wakida, et al.. (2009). Aberrant ENaC activation in Dahl salt-sensitive rats. Journal of Hypertension. 27(8). 1679–1689. 68 indexed citations
13.
Adachi, Masataka & Kimio Tomita. (2006). [Molecular mechanism in biological transport in the kidney: Na+/K(+)-ATPase].. PubMed. 64 Suppl 2. 158–63. 1 indexed citations
14.
Wakida, Naoki, Kenichiro Kitamura, Takuji Miyoshi, et al.. (2006). Inhibition of prostasin-induced ENaC activities by PN-1 and regulation of PN-1 expression by TGF-β1 and aldosterone. Kidney International. 70(8). 1432–1438. 45 indexed citations
15.
Furuhashi, Masato, Kenichiro Kitamura, Masataka Adachi, et al.. (2005). Liddle’s Syndrome Caused by a Novel Mutation in the Proline-Rich PY Motif of the Epithelial Sodium Channel β-Subunit. The Journal of Clinical Endocrinology & Metabolism. 90(1). 340–344. 47 indexed citations
16.
Kitamura, Kenichiro, Taku Miyoshi, Masataka Adachi, et al.. (2005). Effect of Telmisartan on Ambulatory Blood Pressure Monitoring, Plasma Brain Natriuretic Peptide, and Oxidative Status of Serum Albumin in Hemodialysis Patients. Hypertension Research. 28(12). 987–994. 17 indexed citations
17.
Anraku, Makoto, Kenichiro Kitamura, Masataka Adachi, et al.. (2004). Intravenous iron administration induces oxidation of serum albumin in hemodialysis patients. Kidney International. 66(2). 841–848. 87 indexed citations
18.
Okumura, Yuushi, Masazumi Nishikawa, Ping Cui, et al.. (2003). Cloning and Characterization of a Transmembrane-Type Serine Protease from Rat Kidney, a New Sodium Channel Activator. Biological Chemistry. 384(10-11). 1483–95. 4 indexed citations
19.
Shiraishi, Naoki, Kenichiro Kitamura, Yukimasa Kohda, et al.. (2003). Increased endothelin-1 expression in the kidney in hypercalcemic rats. Kidney International. 63(3). 845–852. 11 indexed citations
20.
Narikiyo, Takefumi, Kenichiro Kitamura, Masataka Adachi, et al.. (2002). Regulation of prostasin by aldosterone in the kidney. Journal of Clinical Investigation. 109(3). 401–408. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takayasu Mori Breakdown of academic impact, for papers by Eliezer J. Holtzman Breakdown of academic impact, for papers by Tetsuro Kusaba Breakdown of academic impact, for papers by Taku Miyoshi Breakdown of academic impact, for papers by Andrea Pasini Breakdown of academic impact, for papers by Matthias T. F. Wolf Breakdown of academic impact, for papers by Daryl M. Okamura Breakdown of academic impact, for papers by Liang Fang Breakdown of academic impact, for papers by Kohei Uchimura Breakdown of academic impact, for papers by Weier Qi
Rankless by CCL
2026